Filtros de búsqueda

Lista de obras de Kushtrim Kryeziu

Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells

artículo científico publicado en 2016

Destruxins: fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities

artículo científico publicado en 2013

Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements.

artículo científico publicado en 2017

Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes.

artículo científico publicado en 2016

Nanoformulations of anticancer thiosemicarbazones to reduce methemoglobin formation and improve anticancer activity

scholarly article in RSC Advances, vol. 6 no. 61, 2016

Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activation

artículo científico publicado en 2013

Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis.

artículo científico publicado en 2017

Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates

artículo científico publicado en 2015

Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair

artículo científico publicado en 2013

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo

artículo científico publicado en 2013

The study of reduced versus oxidized glutathione in cancer cell models employing isotopically labelled standards

Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro

artículo científico publicado en 2016

Tumor-targeting of EGFR inhibitors by hypoxia-mediated activation

artículo científico publicado en 2014

Tumorspezifische, Hypoxie-basierte Aktivierung von EGFR-Inhibitoren

Water-Soluble, Biocompatible Polyphosphazenes with Controllable and pH-Promoted Degradation Behavior

artículo científico publicado en 2014

[11C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda